2000
DOI: 10.1177/095632020001100401
|View full text |Cite
|
Sign up to set email alerts
|

Polyanions — A Lost Chance in the Fight against HIV and other Virus Diseases?

Abstract: Polyanions are known to exhibit potent antiviral activity in vitro, and may represent future therapeutic agents. This review summarizes literature reports, pertinent to anionic polymers as antiviral agents. The in vitro antiviral effects of numerous polyanionic compounds (sulphated polysaccharides, negatively charged serum albumin and milk proteins, synthetic sulphated polymers, polymerized anionic surfactants and polyphosphates) are described. This class of antiviral agent exhibits several unique properties t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
107
0
1

Year Published

2004
2004
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 126 publications
(111 citation statements)
references
References 65 publications
3
107
0
1
Order By: Relevance
“…Desulfated HP was nonreactive. Notably, PAs were effective against EEV at concentrations orders of magnitude lower than tested against IMV, where they were largely ineffective (8,25,26). Although anionic charges are important, other polyanionic molecules, including poly-L-glutamic and poly-Laspartic acids, had no effect (Fig.…”
Section: Resultsmentioning
confidence: 98%
See 1 more Smart Citation
“…Desulfated HP was nonreactive. Notably, PAs were effective against EEV at concentrations orders of magnitude lower than tested against IMV, where they were largely ineffective (8,25,26). Although anionic charges are important, other polyanionic molecules, including poly-L-glutamic and poly-Laspartic acids, had no effect (Fig.…”
Section: Resultsmentioning
confidence: 98%
“…PAs ameliorate poxvirus infection by blocking actin tail formation and sensitizing EEV to anti-IMV antibody, therefore providing a significant benefit to the host even after infection has already been established. PAs have an in vitro inhibitory effect on many enveloped viruses, including HIV, herpes, influenza, respiratory syncytial, measles, and parainfluenza viruses (25,26). However, the undesirable properties such as toxicity, short half-life, and inactivity in plasma had led to failure in clinical trials (25).…”
Section: Discussionmentioning
confidence: 99%
“…Large (Ն5 kDa) polyanionic molecules have been shown to be excellent in vitro inhibitors of attachment and entry for several enveloped viruses, including herpesviruses, retroviruses, orthomyxoviruses, and paramyxoviruses (11,32). For many of these viruses, this has been shown to be due to the blocking of important charge-charge interactions involved in the binding of the virus to its cellular receptor(s).…”
Section: Discussionmentioning
confidence: 99%
“…For many of these viruses, this has been shown to be due to the blocking of important charge-charge interactions involved in the binding of the virus to its cellular receptor(s). Such an inhibition is generally dependent upon the molecular weight and extent of the negative charge of the polyanions used and is somewhat nonspecific, in the sense that the interactions are thought to be largely charge mediated and of low affinity and may involve several sites on a particular viral or cellular protein (32). The inhibition of human immunodeficiency virus (HIV) by dextran sulfate, for example, has been shown to involve the association of dextran sulfate with several positively charged regions of the surface glycoprotein gp120 (7,14,22,37,39) and to interfere with the binding of gp160 to its receptor (30,35), coreceptor (39), and cell surface heparan sulfate (38,45).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation